Pediatric Phase 1/Pilot Consortium (U01)

The summary for the Pediatric Phase 1/Pilot Consortium (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pediatric Phase 1/Pilot Consortium (U01): The purpose of the Request for Applications (RFA) reissuance is to continue NCI s program for the development of new anticancer agents for pediatric patients through the Children s Oncology Group (COG) Phase 1/Pilot Consortium. The Consortium will be responsible for timely conduct of the Phase 1 and pilot studies that are essential to NCI s overall clinical research program for children with cancer. This limited competition RFA for the renewal of U01 CA097452 solicits a single application from the Phase 1/Pilot Consortium of the Children s Oncology Group (COG) to continue its drug development activities. The specific objectives for the Consortium in the anticipated 5-year funding period will be: to safely and efficiently introduce novel anticancer agents into the pediatric setting through the conduct of Phase 1 clinical trials; to collaborate with COG Disease Committees to develop and conduct pilot studies of promising new treatment approaches for children with specific types of cancer; and to incorporate pharmacokinetic and pharmacodynamic endpoints (including imaging and translational laboratory studies) as appropriate into Phase 1 and pilot studies to facilitate future development of the new treatment approaches.
Federal Grant Title: Pediatric Phase 1/Pilot Consortium (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-07-502
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.395
CFDA Descriptions: Cancer Treatment Research
Current Application Deadline: No deadline provided
Original Application Deadline: Dec 01, 2006
Posted Date: Sep 08, 2006
Creation Date: Sep 08, 2006
Archive Date: Dec 31, 2006
Total Program Funding: $3,305,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are not eligible to apply. The eligibility to apply in response to this limited competition RFA is limited to the current recipient of the Children s Oncology Group Phase 1/Pilot Consortium award under U01 CA097452.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional)
U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional)
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 -...
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 -...
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognit...
Breast and Prostate Cancer Data Quality and Patterns of Care Study
Consortium Therapeutic Studies of Primary Central Nervous System Malignancies in Adults
National Cooperative Drug Discovery Groups for Cancer
More Grants from the National Institutes of Health
Coordinating Center to Support NIDA Rural Opioid HIV and Comorbidity Initiative (U24 - Cli...
Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Developm...
Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clini...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinica...
Genomic Centers for Infectious Diseases (U19 Clinical Trial Not Allowed) is not endorsed by, or affiliated with, any government agency. Copyright ©2018